The evidence that mitochondrial dysfunction and metabolic mechanisms are associated with ALS neurodegeneration is based on observations of an increased pathological accumulation of glycogen in the CNS of SOD1 mice (Dodge et al., 2013) and an increased lipid metabolism in these mice. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.